Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
Patents for C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883)
04/2003
04/10/2003US20030069312 Nitromethyl ketones, process for preparing them and compositions containing them
04/10/2003US20030069267 Modulators of protein tyrosine phosphatases (PTPases)
04/10/2003US20030069242 3-arylphenyl sulfide derivative and insecticide and miticide
04/10/2003US20030069233 Central nervous system disorders; psychological disorders; Alzheimer's disease
04/10/2003US20030069225 Synthesis of taxol enhancers
04/10/2003US20030069210 Especially imidazolyl- or 1,2,4-triazolyl- pyrimidine derivatives
04/10/2003US20030066988 Electroconductivity coloring
04/10/2003CA2462647A1 6-membered unsaturated heterocyclic compounds useful for selective inhibition of the coagulation cascade
04/10/2003CA2462601A1 Prodrugs of substituted polycyclic compounds useful for selective inhibition of the coagulation cascade
04/10/2003CA2462305A1 6-membered heterocyclic compounds useful for selective inhibition of the coagulation cascade
04/10/2003CA2460594A1 Mch receptor antagonists
04/10/2003CA2459825A1 Compounds useful as reversible inhibitors of cysteine proteases
04/09/2003EP1300430A1 Mono-, oligo- and polymers of benzo[b]thiophene and 2,2'-bisbenzo[b]thiophene and their use as charge transport materials
04/09/2003EP1300405A1 Amino alcohol derivatives
04/09/2003EP1299774A1 Perfluoroalkylsulfonic acid compounds for photoresists
04/09/2003EP1299377A2 Spla2 inhibitors
04/09/2003EP1299376A1 Fatty acid synthase inhibitors
04/09/2003EP1299352A2 Compounds to treat alzheimer's disease
04/09/2003EP1299349A2 Compounds to treat alzheimer's disease
04/09/2003EP1299073A2 Agents for colouring keratin fibres, containing derivatives of benzo(b)furane-3-one and/or benzo(b)thiophene-3-one
04/09/2003EP1178985B1 Substituted thienocycloalk(en)ylamino-1,3,5-triazine
04/09/2003EP0946528B1 OXYGEN OR SULFUR CONTAINING 5-MEMBERED HETEROAROMATICS AS FACTOR Xa INHIBITORS
04/09/2003EP0918746B1 Immunotherapeutic agents and their use in the reduction of cytokine levels
04/09/2003EP0904272B1 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
04/09/2003EP0792257B1 Material for dichroic light polarizers
04/09/2003EP0771197B1 Use of heterocyclic compounds as dopamines-d 3- ligands
04/09/2003CN1409715A Cyclopenteneone derivatives
04/09/2003CN1105116C Thienopyrimidine with PDE V-inhibiting effect
04/09/2003CN1105114C Sulfonyl divalent aryl alpha-hydroxy-iso-hydroximic acid compounds
04/09/2003CN1105112C Benzothiophenecarboxamide derivatives and PGD2 antagonist comprising them
04/08/2003US6545053 Aminoethoxyfluorene derivatives are beta-3 adrenaline receptor agonists and are useful as drugs for the treatment and prevention of diabetes, obesity, hyperlipemia, etc.
04/08/2003US6545049 E.g., (2E, 4E, 6E)-7-(3,5-diisopropyl-2-n-heptyloxyphenyl)-3-methylocta-2,4,6-trienoic acid, esters or amides thereof
04/08/2003US6545027 Methods of modulating NF-kB transcription factor
04/08/2003US6545018 Oxamic acids and derivatives as thyroid receptor ligands
04/08/2003US6544974 (R)-chiral halogenated substituted fused heterocyclic amino compounds useful for inhibiting cholesteryl ester transfer protein activity
04/08/2003CA2123548C Piperazine derivatives
04/08/2003CA2033190C N-phenylalkyl substituted alpha-amino carboxamide derivatives and process for their preparation
04/03/2003WO2003027234A2 Small organic molecule regulators of cell proliferation
04/03/2003WO2003027093A1 Chemical compounds
04/03/2003WO2003027090A2 Bicyclic heterocycles as rxr ligands
04/03/2003WO2003027089A1 Benzofuran, indole or benzothiophene 2,4-pentadienoic acid derivatives having selective activity for retinoid x (rxr) receptors
04/03/2003WO2003027061A2 Muscarinic agonists
04/03/2003WO2003027059A1 Acid amide derivatives, process for producing these, and pest control agent containing these
04/03/2003WO2003026660A1 An enantiomerically pure diarylmethylpiperazine and methods of using same
04/03/2003US20030065187 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
04/03/2003US20030065176 Anticoagulant; cardiovascular disorders
04/03/2003US20030065031 Glucagon antagonists/inverse agonists
04/03/2003US20030065013 Central nervous system analgesic; hypotensive agents; antiarrhythmia agents; antidiabetic agents
04/03/2003US20030064976 Reacting ammonium formate, aldehyde and alkyl isocyanate
04/03/2003US20030064970 Compounds and therapies for the prevention of vascular and non-vascular pathologies
04/03/2003US20030062536 Mono-, oligo- and poly-difluorovinyl-(hetero)arylenes, their synthesis and their use as charge transport materials
04/03/2003US20030062509 Field effect transistor, OLED, electroluminescent device, RFID tag, backlight, photovoltaic or sensor device, or electrophotographic recording device; security marking; charge injection layer, planarising layer, antistatic film
04/03/2003CA2461709A1 Small organic molecule regulators of cell proliferation
04/02/2003WO2002028821A2 Propionic acid derivatives with ppar-alpha activating properties
04/02/2003EP1298133A1 Procedure for the alkylation of 3,4-dihydroxythiophene-2,5-dicarboxylic esters
04/02/2003EP1298130A1 3-hydroxymethylbenzo b thiophene derivatives and process for their preparation
04/02/2003EP1296971A2 2-fluorobenzenesulfonyl compounds for the treatment of inflammation
04/02/2003EP1296945A1 Sulfonamide derivatives
04/02/2003EP1296942A1 Glucagon antagonists/inverse agonists
04/02/2003EP1296940A1 Amidine derivatives as selective antagonists of nmda receptors
04/02/2003EP1296931A2 Polyamine analogues as cytotoxic agents
04/02/2003EP0873295B1 Dimer-selective rxr modulators and methods for their use
04/02/2003EP0741694B1 Phenyl acetic acid derivatives, process and intermediate products for their production and agents containing them
04/02/2003CN1406937A 1-[1-(hetero) aryl-1-perhydroxyalkylmethyl]-piperazine compound, preparation thereof and pharmaceutics containing it
04/02/2003CN1104410C Phenyl acetic acid derivatives, process and intermediate products for their production and agents containing them
04/02/2003CA2424540A1 Propionic acid derivatives with ppar-alpha activating properties
04/01/2003US6541661 Inhibitors of histone deacetylase
04/01/2003US6541655 Catalytic compositions and methods for asymmetric allylic alkylation
04/01/2003US6541521 Benzene butyric acids and their derivatives as inhibitors of matrix metalloproteinases
04/01/2003US6541506 Enediyne carboxylated on one end and having a pyrrole, furan or thiophene ring on the other; may be isolated from annarrhinum bellidofolium
04/01/2003US6541498 Benzenesulfonamides and the use thereof to modulate the activity of endothelin
04/01/2003US6541489 Excellent inhibitory activity of one or more matrix metalloprotease (MMP) enzymes, such as MMP-2, MMP-9, and MMP-13, while exhibiting substantially less inhibition at least of MMP- 1
04/01/2003US6541475 2-nitrostyryl-1-(naphthylmethyl)sulfone for example
04/01/2003US6541473 Resorcinol derivatives
04/01/2003US6540793 Coupler for use in oxidative hair dyeing
03/2003
03/28/2003WO2002030869A1 5-amino-1-pentene-3-ol substituted derivatives
03/28/2003CA2424103A1 Substituted 5-amino-1-penten-3-ol derivatives
03/27/2003WO2003025017A1 Cytokine receptor
03/27/2003WO2003024955A2 Small molecule inhibitors of caspases
03/27/2003WO2003024954A1 Novel terthiophene-3-carboxylic acid compound and fabricating method thereof, functionalized conductive terthiophene polymer with the compound as a monomer, process for dna hybridizatioon detection using the polymer, and fabricating method of probe dna
03/27/2003WO2003024946A2 Oxamate derivatives containing a variously substituted nitrogen heterocycle
03/27/2003WO2003024935A2 Substituted pyrazolyl compounds for the treatment of inflammation
03/27/2003WO2003024933A1 2-phenyl-3-heteroarylpropionic acid derivative or salt thereof and medicine containing the same
03/27/2003WO2003024920A1 Substituted urea retinoid agonists ii
03/27/2003WO2003024448A2 Inhibitors of histone deacetylase
03/27/2003WO2003024439A1 Phenethanolamine derivatives for treatment of respiratory diseases
03/27/2003WO2002014261A3 4-substituted d-glutamic acid derivatives for use as antibiotic
03/27/2003WO2001092218A3 Polyamine analogues as therapeutic and diagnostic agents
03/27/2003US20030060638 C7 carbamate substituted taxanes
03/27/2003US20030060491 Bicyclic aromatic compounds
03/27/2003US20030060461 Cyclic diamine compound with condensed-ring groups
03/27/2003US20030060460 Sulfonamide and carboxamide derivatives and drugs containing the same as the active ingredient
03/27/2003US20030060456 Such as 4-(2,3-dihydro-1-benzothien-5-yloxy)-3-((methylamino) methyl)-benzenesulfonamide for use as serotonin re-uptake inhibitors (SSRIs) in treatment of depression, attention deficit hyperactivity disorder, obsessive-compulsive disorder
03/27/2003US20030060452 N-heterocyclic derivatives as NOS inhibitors
03/27/2003CA2465978A1 Inhibitors of histone deacetylase
03/27/2003CA2460942A1 Substituted pyrazolyl compounds for the treatment of inflammation
03/27/2003CA2460151A1 Cytokine receptor
03/27/2003CA2460149A1 2-phenyl-3-heteroarylpropionic acid derivative or salt thereof and medicine containing the same
03/26/2003EP1295872A1 Drug composition antagonistic to both pgd 2?/txa 2? receptors
03/26/2003EP1295868A1 Amide compounds and use thereof
1 ... 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 ... 329